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Abstract
Background: X monosomic mice (39,XO) have a remarkably mild phenotype when compared to women with Turner 
syndrome (45,XO). The generally accepted hypothesis to explain this discrepancy is that the number of genes on the 
mouse X chromosome which escape X inactivation, and thus are expressed at higher levels in females, is very small. 
However this hypothesis has never been tested and only a small number of genes have been assayed for their X-
inactivation status in the mouse. We performed a global expression analysis in four somatic tissues (brain, liver, kidney 
and muscle) of adult 40,XX and 39,XO mice using the Illumina Mouse WG-6 v1_1 Expression BeadChip and an 
extensive validation by quantitative real time PCR, in order to identify which genes are expressed from both X 
chromosomes.
Results: We identified several genes on the X chromosome which are overexpressed in XX females, including those 
previously reported as escaping X inactivation, as well as new candidates. However, the results obtained by microarray 
and qPCR were not fully concordant, illustrating the difficulty in ascertaining modest fold changes, such as those 
expected for genes escaping X inactivation. Remarkably, considerable variation was observed between tissues, 
suggesting that inactivation patterns may be tissue-dependent. Our analysis also exposed several autosomal genes 
involved in mitochondrial metabolism and in protein translation which are differentially expressed between XX and XO 
mice, revealing secondary transcriptional changes to the alteration in X chromosome dosage.
Conclusions: Our results support the prediction that the mouse inactive X chromosome is largely silent, while 
providing a list of the genes potentially escaping X inactivation in rodents. Although the lower expression of X-linked 
genes in XO mice may not be relevant in the particular tissues/systems which are affected in human X chromosome 
monosomy, genes deregulated in XO mice are good candidates for further study in an involvement in Turner 
Syndrome phenotype.
Background
The existence of dimorphic sex chromosomes poses a chal-
lenge to the balance of gene dosage between the sexes. In
mammals, X chromosome inactivation is the mechanism by
which the equality in gene expression between males and
females is restored, through the transcriptional silencing of
one of the X chromosomes in females. Dosage compensa-
tion between X-linked and autosomal genes is also
achieved, through the upregulation of the active X chromo-
some in females and the single X chromosome in males [1].
In eutherian mammals, one X chromosome is randomly
inactivated in the cell lineages of the embryo proper, early
in development. The initiation of X-inactivation is con-
trolled by a region on the X chromosome, the X-Inactiva-
tion Centre (XIC in humans and Xic in mice), which
contains the X-Inactive-Specific Transcript locus (XIST/
Xist), a noncoding RNA essential for silencing, and several
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Page 2 of 13other genetic elements (reviewed by [2]). The nature of
their interactions and the succession of events that results in
the global repression of X-linked genes are not fully under-
stood, being the focus of active research [3,4]. Once initi-
ated, a wave of silencing spreads through the entire
chromosome and the transcriptionally silent state is stably
maintained on the inactive X chromosome by various epi-
genetic modifications, such as histone modifications and
DNA methylation [2,5] and inherited clonally in subse-
quent cell divisions.
Although X inactivation is a very effective mechanism
some genes are expressed from the inactive X chromosome
[6]. Using in vitro models Carrel and Willard [7] performed
a systematic analysis of human X-linked transcripts and
predicted that approximately 15% of the genes on the
human X chromosome escape X inactivation to variable
extents. In the mouse only a few "escapees" have been
reported [8-12] and the finding of differences in the inacti-
vation status of several genes in a conserved region
between the human and mouse X chromosomes has been
taken as evidence that the mouse X chromosome is depleted
of genes escaping X inactivation [13]. Although the mecha-
nisms of escape are still poorly understood, from the analy-
sis of sequence features within the relevant regions in
human and in the mouse, the authors suggested that both
genomic context and gene-specific regulatory elements are
involved. In particular, long terminal repeats (LTRs) are
more frequent in a smaller human X chromosome domain
where all genes escape inactivation, compared to the syn-
tenic region in the mouse, where only one of the genes,
Jarid1c, is expressed from the inactive X [13]. Addition-
ally, several binding sites for the insulator protein CTCF
were identified in the 5' end of Jarid1c but not in its human
homologue (JARID1C), raising the hypothesis that this pro-
tein may be required to prevent the spreading of silencing
epigenetic marks to Jarid1c, which is embedded in inactive
chromatin on the mouse X chromosome [14]. Recently, the
analysis in female ES cells of chromatin modifications
accompanying XCI has revealed an increase of H3K27me3
throughout the inactive X chromosome, as inactivation pro-
ceeds, and a preferential localisation of this silencing mark
over active genes [15]. The characterization of a larger
number of genes expressed from the inactive X chromo-
some in the two species would certainly contribute to a bet-
ter understanding of the process of escape, but a
comprehensive search for genes escaping inactivation on
the mouse X chromosome is still lacking.
In recent reports, microarray technology was used to
compare gene expression between males and females in
several mouse tissues, from which indirect evidence of
escape from X inactivation can be derived [1,16,17]. Nev-
ertheless in these analyses it is difficult to disentangle the
effects of sex hormones in the regulation of gene expression
and, as later demonstrated using manipulated mice [18],
these are indeed substantial. In the mouse model used to
demonstrate this, the gonadal phenotype (ovaries or testis)
is independent of the sex chromosome complement (XX or
XY) and therefore it circumvents the confounding effects of
differential hormonal status. This strategy had been previ-
ously used by Xu and collaborators to investigate expres-
sion levels of several sex-linked genes in brain and it was
demonstrated that Eif2s3x, Jarid1c, Utx and Usp9x were
more highly expressed in the XX genotype, compared to
XY, regardless of the gonadal phenotype [19-23], which
further suggests that these genes escape X inactivation in
the mouse.
The 39,XO mouse is another valuable model to assess the
impact of the number of X chromosomes on the level of X-
linked gene expression in a similar hormonal milieu, using
a simple experimental design. The underlying assumption
is that genes that are expressed from both the active and
inactive X chromosomes would be expressed at higher lev-
els in the XX females than in their XO littermates. We gen-
erated three genotypes (XmO, XpO and XmXp) using the
breeding strategy of Davies et al.[24]. The XO mice are
free from cryptic mosaicism and although the mice are on a
random bred genetic background, all the X chromosomes
were recently derived from a single progenitor and thus
should be identical.
X monosomic mice (39,XO) have a remarkably mild phe-
notype when compared to women with Turner Syndrome
(45,XO). In fact, while XO mice are fertile and do not dis-
play major physiological abnormalities, TS females present
ovarian dysgenesis and other anatomical and physiological
abnormalities [25]. A spectrum of neuropsychological defi-
cits is also associated to X chromosome monosomy in
humans and, to some extent, in the mouse [24-27]. The
main candidates for the TS phenotype are those genes
escaping X inactivation in humans but not in the mouse.
However, the global degree of escape on the mouse X chro-
mosome is presently unknown.
We present a global expression analysis in somatic tissues
of XX and XO mice, using a microarray platform that
allows a genome-wide survey of gene expression, followed
by a detailed qPCR inspection of the candidate genes. Our
analysis identified new genes potentially escaping X inacti-
vation in the mouse and sheds some light on the transcrip-
tional networks regulated by X-linked genes which are
disturbed in X chromosome monosomy.
Results
We performed a genome-wide expression profiling in four
different tissues of adult XX and XO mice (brain, liver, kid-
ney and muscle), using the Illumina Mouse WG-6 v1_1
Expression BeadChip, which covers more than 45,000 tran-
scripts and includes 1,326 probes interrogating the X chro-
mosome transcriptome. According to our manual
annotation these correspond to 970 different genes, thus
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some - on the latest Ensembl release (55, July 2009),
approximately 1000 protein coding genes were annotated
on the X chromosome. Brain was the tissue where the larg-
est number of probes was detected (24,873 were called
present in at least one of the samples), while 19,887 probes
were detected in liver, 23,427 in kidney and in muscle
21,820. High values were obtained for the correlation coef-
ficients (r) between biological replicates (0.98 to 1), indi-
cating that the platform and methods applied are extremely
robust. This high reproducibility is also likely due to the
pooling of individuals of the same genotype (we analyzed 3
pools of at least two individuals for each genotype), which
minimizes the differences between individuals. After nor-
malisation the samples were hierarchically clustered
according to their global expression profiles, to verify the
biological accuracy of the data. The samples clustered pri-
marily by tissue and in general also by genotype, as
expected (results not shown).
In the chosen array platform 19,100 probes represent
unique curated genes in the NCBI RefSeq database (Build
36, Release 22). We annotated all the remaining probes, by
performing automated blast searches followed by a manual
curation using combined information from several data-
bases - NCBI http://www.ncbi.nlm.nih.gov, MGI http://
www.informatics.jax.org/ and SOURCE http://smd.stan-
ford.edu/cgi-bin/source/sourceSearch. This allowed us to
determine the total number of X-linked transcripts
expressed in each tissue and to perform a targeted analysis
for each dataset. On the X chromosome the highest number
of probes was detected in brain (725 present in at least one
of the pools), while in liver only 538 were detected; 643
were expressed in kidney and 605 in muscle.
As a preliminary analysis of autosomal and X-linked
expression in the two groups we plotted the median of the
normalised hybridization signals of the XO mice against the
XX in each of the four tissues analyzed (Figure 1). In these
graphs, the majority of points, representing both autosomal
and X chromosome genes, lie within a diagonal where
expression is equivalent between groups, indicating that the
majority of genes are expressed at similar levels in the two
groups. An obvious outlier is present in all graphs, repre-
senting Xist, an expected observation since this gene is only
transcribed from the inactive X chromosome in XX
females; a few scattered X-linked genes can be detected
which also lie above the diagonal, particularly in liver.
Differential gene expression on the X chromosome
Recently, several statistical approaches to detect differential
gene expression from microarray data have been compared
[28] and it was established that empirical Bayes methods
perform better than standard t-tests, particularly when the
sample size is small. Therefore, to test if those genes
located on the X chromosome were differentially expressed
between the two groups of mice, we employed a pairwise
comparison using an Empirical Bayesian approach, limma
[29], which fits a linear model of gene expression to the
data. This is a moderate version of the t-statistic where the
gene-specific variance estimator takes into account the data
from all genes [30]. This variance stabilising approach is
very robust to between-sample variation. The resulting p-
values were corrected for multiple tests by setting the FDR
(False Discovery Rate) to 0.05 and number of comparisons
equal to the total number of X chromosome probes detected
in each tissue. Finally we tested several candidates by quan-
titative real time PCR in different tissues. The probes sig-
nificantly overexpressed in XX mice are listed in Table 1,
where the respective p-value obtained from the array data
after FDR correction is also indicated. Fold-change (FC)
estimates obtained with both techniques are also included
for reference, although these should be regarded with cau-
tion, since they do not take into account the variation of the
samples.
At the 0.05 significance level (adjusted p-value) different
groups of probes were found to be significant in each tissue;
Xist was the only probe significantly different between the
two groups of mice in all tissues (P < 0.0001).
Eif2s3x, which is ubiquitously expressed and known to
escape X-inactivation in both human and mice [11] is more
highly expressed in XX mice in all tissues analyzed,
although in brain the difference did not reach significance
by microarray. Two of the three probes present in the array
representing Utx, one other well known escapee [10,12],
were significantly different between groups in our analysis,
presenting a FC higher than 1.3 in all tissues except brain
and a third probe was significant in liver and kidney.
Although in brain none of the probes for this gene was sig-
nificant, by real time PCR the corresponding transcript was
detected more abundantly in XX mice (FC = 1.38 ± 0.14; P
< 0.05). Jarid1c, also shown to escape X inactivation in the
mouse [8], presented a modest fold change in all tissues,
reaching significance in liver by microarray (FC = 1.12; P <
0.01) and qPCR (FC = 1.53 ± 0.06; P < 0.05), and in muscle
only by qPCR (1.43 ± 0.01; P < 0.05). In kidney and brain
the difference in Jarid1c expression between the two
groups was not significant.
Only a small number of genes were differentially
expressed between the two genotypes in muscle and kidney
and in brain none of the probes reached the significance
threshold. However, the established escapees Eif2s3x and
Utx were significantly overexpressed in the brain of XX
females by qPCR, as well as Ddx3x (formerly Dbx), a
potential escapee that had been found to be more highly
expressed in female compared to male brain by Northern
Blot [19]. In our microarray analysis Ddx3x was signifi-
cantly more abundant in XX females in liver but it did not
reach significance in any of the other tissues tested.
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different genes, were significantly overexpressed in XX
mice (Table 1); Eif2s3x, Utx, Ddx3x and Jarid1c were all
highly significant (P ≤ 0.01). The fold change differences in
expression between the two groups in this tissue ranged
from 1.1 to 1.8 for the probes with significant p-values
although some were expressed at low levels in both groups
(Ogt, Cetn2, Arhgef6, Jarid1c, Slc6a8, Sytl4, Was and
Gm732). The limma analysis we performed also produces a
B-statistic, the log-odds that a gene is differentially
expressed, which provides an additional measure of the
strength of each candidate. The 11 probes presenting the
largest p-values in liver all present a B < 0 and have there-
fore less than 50% chance of being differentially expressed.
Pgk1, a gene that undergoes X inactivation, is amongst
these, although presenting a small FC. We tested one other
gene with B < 0 by qPCR (Pgrmc1) but could not confirm
differential expression (FC= 1 ± 0.21; P > 0.05), advising
caution in considering these 11 genes as differentially
expressed.
The array also includes a probe annotated as representing
Sts (Steroid Sulfatase), a gene in the mouse pseudoauto-
somal region. Keitges et al. [31] have suggested that this
gene escapes inactivation, based on the comparison of the
level of enzyme activity in somatic tissues of XX, XO and
XY mice. There are, however other reports with conflicting
results in the literature [31-33]. According to our microar-
ray analysis Sts is not differentially expressed in any of the
tissues tested and we were unable to design appropriate
primers on exon-exon boundaries in order to validate our
microarray results by quantitative PCR, since the genomic
sequence of Sts was not available in any of the databases
searched (NCBI, UCSC Genome Browser and Ensembl). A
Blat search http://genome.ucsc.edu/cgi-bin/hgBlat?com-
mand=start of the probe sequence retrieved no matches,
indicating that the gene is not on the current genome assem-
bly (July 2007). Enox (AK137473), another gene recently
described as escaping X inactivation [34] is not represented
on the array.
We analysed several of the significant genes by both
microarrays and qPCR. At present, a standard definition of
Figure 1 Plots of the normalised hybridisation signals of XO versus XX mice in four tissues. In black are represented autosomal probes and X-
linked genes are in red; the diagonal (in grey) lies at the intersection of points where median expression is equal between groups. The most noticeable 
X-linked outlier corresponds to Xist. A- Brain, B- Muscle, C- Liver, D- Kidney.
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Array qPCR P-value Array qPCR
1,35 1,83±
0,26
>0,05 1,38 1,79±
0,33
1,60 2,04±
0,24d
>0,05 1,12 1,38±
0,14e
1,46 2,04±
0,24d
>0,05 1,17 1,38±
0,14e
1,02 - >0,05 1,08 -
ND ND ND ND ND
1,09 1,33±
0,10
>0,05 1,08 1,56±
0,24
1,13 2,04±
0,24d
>0,05 1,04 1,38±
0,14e
1 - >0,05 0,98 -
0,94 - >0,05 1,02 -
0,89 - >0,05 1,06 -
0,88 - >0,05 1,05
0,97 - >0,05 0,97 -
0,96 - >0,05 0,93 -
0,93 - >0,05 0,97 -
0,94 - >0,05 0,95 -
0,97 - >0,05 1 -
0,86 - >0,05 0,88 -
1,12 1,43±
0,01
>0,05 1,06 1,16±
0,14L
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Table 1: Probes overexpressed in XX versus XO mice in each tissue
Liver Kidney M
FC FC
Probe ID Gene P-value Array qPCR P-value Array qPCR P-value
2649129 Eif2s3x 6,17E-
07
1,79 1,54±
0,21
1,81E-
03
1,48 1,43±
0,02
1,11E-
02
2447456 Utx 4,79E-
05
1,34 1,97±
0,35a
2,16E-
03
1,37 1,88±
0,15c
1,53E-
03
2506528 Utx 4,96E-
05
1,62 1,97±
0,35a
1,98E-
04
1,51 1,88±
0,15c
4,83E-
03
2508945 Lamp2 1,69E-
04
1,29 1,04±
0,10
>0,05 1,03 - >0,05
2700885 Rgn 8,07E-
04
1,38 - ND ND ND ND
2710166 Ddx3x 9,17E-
04
1,49 1,44±
0,25
>0,05 1,27 1,08±
0,10
>0,05
1235933 Utx 2,25E-
03
1,18 1,97±
0,35a
3,35E-
03
1,18 1,88±
0,15c
>0,05
1231201 Pja1 2,30E-
03
1,22 1,24±
0,26
>0,05 1,08 1,33±
0,08
>0,05
2473374 Zdhhc9 2,47E-
03
1,18 - >0,05 1,01 - >0,05
1249467 Rap2c 3,13E-
03
1,45 - >0,05 1,18 - >0,05
1220409 Cetn2 3,18E-
03
1,17 - ND ND ND >0,05
2605212 Slc6a8 3,27E-
03
1,25 - >0,05 0,95 - >0,05
2494747 Huwe1 3,51E-
03
1,31 - >0,05 1,11 - >0,05
2540573 LOC665281 4,61E-
03
1,34 - >0,05 1,05 - >0,05
1247078 Ogt 7,74E-
03
1,11 1,12±
0,14b
>0,05 1,05 - >0,05
1236901 Maob 8,04E-
03
1,17 1,04±
0,06
>0,05 1,02 - >0,05
1225930 LOC100039346 8,16E-
03
1,28 - >0,05 1,06 - >0,05
1253604 Jarid1c 8,93E-
03
1,12 1,53±
0,06
>0,05 1,13 1,32±
0,19
>0,05
0,85 - >0,05 1,06 -
0,83 - >0,05 1,02 -
1,44 1,27±
0,14
>0,05 1,27 1,21±
0,10
1,03 - >0,05 0,81 -
1 - >0,05 0,93 -
0,83 - >0,05 0,87 -
0,96 - >0,05 1,02 -
1 - >0,05 0,98 -
1 - >0,05 0,98 -
0,98 - >0,05 0,85 -
0,94 - >0,05 0,99 -
0,98 - >0,05 0,99 -
0,97 - >0,05 1 -
1,04 - >0,05 0,97 -
0,99 - >0,05 0,95 -
1 - >0,05 0,98 -
1,30 - >0,05 1,05 -
1,15 1,22 ± 
0,27
>0,05 0,76 -
X chromosome probes were considered. P-values were derived 
icated (a,b,c,d,e - each of these values refers to a measurement 
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2740445 Nsbp1 9,76E-
03
1,31 0,97±
0,02
>0,05 0,98 - >0,05
1251370 Ndufa1 9,78E-
03
1,15 1,13±
0,30
>0,05 0,84 - >0,05
2694999 2610029G23Rik 9,88E-
03
1,19 1,24±
0,12
2,53E-
03
1,26 1,45±
0,24
4,88E-
04
2639642 Arhgef6 9,90E-
03
1,12 - >0,05 1,04 - >0,05
2751935 Sytl4 1,19E-
02
1,13 - >0,05 1,09 - >0,05
2623216 Pgrmc1 1,29E-
02
1,41 1±0,2
1
>0,05 1,11 - >0,05
2651886 Pgk1 2,32E-
02
1,19 - >0,05 1,01 - >0,05
2590998 Acsl4 2,38E-
02
1,21 - >0,05 0,95 - >0,05
1236524 Msn 2,77E-
02
1,15 - >0,05 0,93 - >0,05
2611676 Ogt 2,82E-
02
1,16 1,12±
0,14b
>0,05 1,1 - >0,05
2637249 Bgn 2,85E-
02
1,14 - >0,05 0,95 - >0,05
1212894 Cask 3,09E-
02
1,15 - >0,05 1,03 - >0,05
2501489 Was 3,19E-
02
1,10 - >0,05 1,05 - >0,05
1220398 Armcx2 3,20E-
02
1,17 - >0,05 1,09 - >0,05
1229474 Gm732 4,42E-
02
1,10 - >0,05 1,02 - >0,05
2423331 Rbmx 4,54E-
02
1,09 - >0,05 0,99 - >0,05
1246006 Armcx4 >0,05 0,98 - >0,05 0,98 - 1,84E-
02
1244364 Pnck ND ND ND ND ND ND 1,88E-
02
Indicated are the probes (Illumina ID) which were significantly different in each tissue in the pairwise comparison of XX and XO mice, where only the 
from limma followed by FDR correction. For selected genes, fold changes obtained by qPCR (mean of two experiments ± standard error) are also ind
using one pair of primers). In bold are the genes for which significant p-values were obtained by both methods in at least one tissue. Xist was not inc
qPCR, quantitative real-time PCR; FC, fold-change.
Table 1: Probes overexpressed in XX versus XO mice in each tissue (Continued)
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Page 7 of 13validation of microarray results by qPCR is still lacking and
it is common practice to simply compare FC values. We
required significant p-values in both methodologies as cri-
teria for full concordance. This is especially important
when small expression differences between groups are
sought and it is difficult to define a fold change cut-off
value. Five of the genes that were significant by microarray
analysis were tested by qPCR in all four tissues (Eif2s3x,
Utx, Ddx3x, Jarid1c and 2610029G23Rik). Overall, FC
estimates obtained by both methods were roughly concor-
dant and all genes were significantly overexpressed by
qPCR in at least one of the tissues tested (see Table 1). Pja1
was significant by microarray in liver but by qPCR the dif-
ferences did not reach significance in liver or kidney, the
two tissues where the expression levels allowed the deter-
mination of reliable standard curves, although the FC esti-
mates obtained were similar. We could not confirm Lamp2
and Nsbp1 overexpression in liver by qPCR (1.04 ± 0.10; P
< 0.05) and therefore these genes were not tested in the
other tissues. Additionally, four of the significant genes pre-
senting FC < 1.2 were tested (Ogt, Maob, Ndufa1 and
Pnck); by qPCR only Pnck was significantly overexpressed
(FC = 1.22 ± 0.27; P < 0.05).
Amongst the transcripts that reached the significance
level in more than one tissue by both approaches, one has
not been previously described as escaping X inactivation
(2610029G23Rik). The function of 2610029G23Rik and its
human homologue CXorf26 have not yet been determined.
Analysis of allelic expression
To definitely prove escape from X inactivation, expression
from both the active and the inactive X chromosomes
should be demonstrated. Ideally single cell analysis should
be performed, since every female is a mosaic of cells with
either the maternal or the paternal X chromosome active
and therefore in a tissue homogenate of a heterozygous
female, expression from both alleles would be detected not
only from those genes escaping X inactivation but also
from inactive genes. Alternatively a system in which X
inactivation is skewed towards one of the X chromosomes
can be used, such as 40,T(X;16)16H female mice carrying
the Searle's translocation. In these females the normal X
chromosome is always inactive [35] and therefore biallelic
expression, detected through the analysis of sequence poly-
morphisms, indicates escape from X inactivation. We have
analysed the transcripts of three of the genes detected as
differentially expressed in our microarray analysis in cDNA
samples of the F1 females of a cross between a T(X;16)16H
female, kept on a mixed C3H/He and 129/Sv background,
and a FVB/NHsd male. Two of the F1 females from this
cross presented DNA sequence polymorphisms within the
coding region and/or the UTRs of Huwe1, Arhgef6 and
Nsbp1; however, for all three genes tested, at the cDNA
level only the allele derived from the active X chromosome
was detected by direct sequencing and single-base primer-
extension (SNaPshot) (Table 2). The second method is also
based in a fluorescent dideoxy terminator reaction and has
been applied previously to the detection of allele-specific
expression on the X chromosome [7]. We were therefore
unable to demonstrate expression from both X chromo-
somes, for these candidate genes.
Secondary transcriptional alterations
In view of the larger number of X-linked probes found to be
more highly expressed in the liver of XX mice, we per-
formed a second analysis including all probes in the array
which were detected in this tissue, to verify if any auto-
somal transcripts were deregulated between the two groups
of mice. In this genome-wide analysis 1402 probes (out of
19,887) were significantly different between genotypes at
the 0.05 significance level after correcting for the number
of genes tested (see Additional file 1); of these, 686 (34
annotated to the X-linked and 584 to the autosomes) were
detected more abundantly in XX mice, while the remaining
716 (14 annotated to the X chromosome and 673 to the
autosomes) were more highly expressed in the XO geno-
type. We confirmed by qPCR one of the autosomal genes
significantly overexpressed in XX females in liver, Argini-
nosuccinate synthetase 1, Ass1 (FC = 1.49 ± 0.27; P <
0.05), which codes for one of the enzymes of the arginine
biosynthetic pathway. Interestingly, the autosomal genes
Eif2b2 and Eif2b5, which encode two of the subunits of the
eukaryotic translation initiation factor 2B, were amongst
the most significant probes in this genome-wide compari-
son (P = 0.005 and P = 0.007, respectively). In humans,
mutations in these genes have been detected in females with
POF (Premature Ovarian Failure) and it has been hypothe-
sized that EIF2B2 dysfunction in humans may be related to
increased apoptosis of ovarian follicles [36].
To further clarify if the alterations observed in autosomal
gene expression were specific to liver, and are thus more
likely downstream effects of the differential expression
detected for several X-linked genes in this tissue, we
extended the genome-wide statistical analysis to the
remainder of the tissues. In kidney and muscle datasets only
a small number of genes were detected as differentially
expressed at a 0.05 significance level after FDR correction
(6 genes in kidney: Clic6, 2510022D24Rik, Erdr,
11810009N02Rik, LOC100047358, Rtn4; 3 genes in mus-
cle: Kremen, Casq1, Rab33b). Therefore the autosomal
expression perturbations were more pervasive in the liver of
monosomic mice, where the differences in X-linked expres-
sion are more pronounced.
Enrichment of functional categories
We performed a functional enrichment analysis for the liver
dataset in FatiGO http://www.babelomics.org/, by compar-
ing the Gene Ontology (GO) terms corresponding to the
significant genes detected at the genome-wide level (1340
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Page 8 of 13annotated genes after removing duplicates; Additional file
1) to the list of all probes present in the array (14,964 anno-
tated probes after removing duplicates), by means of a
Fisher's exact test.
Several terms related to metabolic and biosynthetic path-
ways, namely energy metabolism, were overrepresented in
the set of significant genes and cytoplasmic/mitochondrial
subcellular location was also more frequent (Table 3). Sev-
eral of the genes coding for NADH dehydrogenase sub-
units, the first enzyme (complex I) of the mitochondrial
electron transport chain, are differentially expressed
between XX and XO mice, although there is no clear trend
towards an up- or down-regulation of the autosomal com-
ponents of this enzymatic complex. Ndufa1, the subunit
encoded by an X-linked gene, is significantly overex-
pressed in XX females by microarray but not by qPCR. The
modest increase in expression of this gene, as well as the
differences found in other energy metabolism genes, such
as Cytochromeb5 Reductase1 (Cyb5r1) and the Crystallin
Zeta quinone reductase (Cryz), and in genes encoding other
mitochondrial proteins, may be due to a global alteration of
the gene expression networks relevant for mitochondrial
metabolism.
Enrichment of transcription factor binding sites
Considering that several functional categories are overrep-
resented in our liver dataset it is plausible that the expres-
sion of some X chromosome genes may be perturbed
indirectly through the action of shared transcription factors
within an expression network. To further explore this
hypothesis we searched for conserved binding sequences
for known transcription factors within the 5000 bp
upstream and downstream the TSS of those genes that were
overexpressed in XX compared to XO females and per-
formed an analysis of TFBS enrichment using the oPOS-
SUM web tool http://www.cisreg.ca/oPOSSUM/.
Following FDR correction the genes overexpressed in liver
showed enrichment for six transcription factors (NKX3-1,
Lhx3, HLF, Foxa2, Prrx2, Foxd3; P < 0.05, Fisher's exact
test).
Interestingly, several overexpressed genes located on the
X chromosome, including Huwe1, Arhgef6 and Nsbp1,
present TFBS for one or more of these transcription factors.
It seems plausible that in XX females higher transcriptional
output of some of the genes that escape X inactivation may
lead to a secondary upregulation of other genes on the X
chromosome belonging to the same transcriptional net-
works, which will therefore be overexpressed even though
not escaping X-inactivation.
Discussion
In the present analysis we aimed to detect differences in X-
linked expression between XX and XO mouse females in
four different tissues, to fully characterize the genes escap-
ing X inactivation in this model and to increase our under-
standing of the basis of the different phenotypes of X
monosomic females in humans and mice.
The identification of genes differentially expressed
through the statistical analysis of microarray data represents
a challenge and the application of this technique to the iden-
tification of genes escaping X inactivation is of added diffi-
culty. Due to the biological nature of the differences we
were aiming to detect, i.e., expression from the active X
chromosome, which is inherently upregulated [1], and from
the inactive X, which should reach at most half of that of its
counterpart, a modest overexpression of a maximum of 1.5-
fold is expected between groups for those genes escaping
inactivation [37]. In fact, it has been demonstrated experi-
mentally that expression from the inactive X chromosome,
Table 2: Allelic expression analysis in T16H mice
Female 1 Female 2
gDNA cDNA gDNA cDNA
Huwe1 rs29297624 CT C CT C
rs29296351 CG G CG G
rs29294894* GT G GT G
rs29295859 CT C CT C
Arhgef6 rs13475263* AC A AC A
Nsbp1 rs29091513* CT C CT C
Allelic expression of X chromosome genes in two F1 females, from a cross of a 40,T(X;16)16H female and an FVB/NHsd male, detected in 
genomic DNA (gDNA) and in cDNA from different tissues (liver, kidney, muscle and brain). All SNPs in the table were analysed by direct 
sequencing in liver; those marked as * were also verified by SNaPshot in liver, kidney, muscle and brain. In all cases only the allele on the X 
chromosome carrying the translocation (active) was detected in the cDNA.
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Page 9 of 13compared to the active X, can be as low as 5%-15% [7].
Therefore, minor differences between XX and XO mice for
genes escaping X inactivation are not unexpected.
While there was an overall agreement on the direction of
change obtained by microarray and qPCR in our study, the
concordance between the two approaches was not com-
plete. It is widely accepted that several factors can contrib-
ute to discrepancies between microarray and qPCR data and
each technique presents advantages and pitfalls. In a recent
assessment it has been established that even though lower
fold changes in microarray data (<1.4) are less likely to be
confirmed by qPCR, the most determinant factor in obtain-
ing a high correlation for these two approaches is the
microarray data p-value [38]. The same trend is supported
by our results.
The most consistent results across tissues, obtained by
both methods, were those of two of the genes previously
demonstrated to escape X inactivation, Eif2s3x and Utx,
and for a new candidate gene (2610029G23Rik). Jarid1c,
also known to escape X inactivation, and Ddx3x, a potential
escapee, only reached significance by both methods in liver.
Variable expression from the inactive X chromosome
across tissues has been reported for Jarid1c [39,40] and
may have a bearing on the results, since very small expres-
sion differences may be beyond the detection limit of both
approaches.
The majority of the genes detected as differentially
expressed were only so in one of the tissues analyzed, with
liver presenting a noticeably larger number of genes signifi-
cantly overexpressed. Several factors may underlie these
observations. Variable escape from inactivation has been
observed in rodent-human somatic cell hybrids and in
human cell lines [7,41] as well as across human [42] and
mouse tissues [39,40] and therefore inactivation patterns of
some genes may be tissue- or even cell-type specific. Tissue
composition is also likely to be contributing to the differ-
ences observed, particularly in brain, an organ with very
complex tissue architecture, where we and others [43] were
unable to detect significant differences between XX and
XO mice by microarray, even though a high proportion of
genes on the X chromosome are highly expressed in this tis-
sue [1].
For several genes, more than one probe was detected and,
in many cases, different probes were not concordant in
defining a gene as significantly overexpressed, even in the
same tissue. A careful analysis revealed that those probes
with discordant results were often derived from genomic
sequences that were not included in all transcripts of a
given gene. Therefore, the existence of alternative splicing
is contributing to some extent to the heterogeneity observed
between tissues. Additionally, our analysis of enrichment of
functional categories and TFBS within the group of differ-
entially expressed genes suggests that secondary transcrip-
tional regulation has an impact on the expression level of
Table 3: GO biological processes overrepresented in the list 
of deregulated genes in liver
GO group P-value
cytoplasmic part 
(GO:0044444)
3,35E-10
cytoplasm (GO:0005737) 2,11E-09
mitochondrion 
(GO:0005739)
6,64E-07
ribonucleoprotein complex 
(GO:0030529)
1,23E-04
mitochondrial part 
(GO:0044429)
1,92E-04
intracellular part 
(GO:0044424)
1,19E-03
biosynthetic process 
(GO:0009058)
1,69E-03
organelle envelope 
(GO:0031967)
1,85E-03
organelle inner membrane 
(GO:0019866)
2,22E-03
cellular metabolic process 
(GO:0044237)
4,51E-03
intracellular (GO:0005622) 6,98E-03
membrane-bound organelle 
(GO:0043227)
7,50E-03
organelle part (GO:0044422) 7,50E-03
ribosome (GO:0005840) 1,24E-02
cellular biosynthetic process 
(GO:0044249)
1,60E-02
organelle membrane 
(GO:0031090)
1,65E-02
translation (GO:0006412) 1,66E-02
intracellular membrane-
bound organelle 
(GO:0043231)
2,52E-02
intracellular organelle part 
(GO:0044446)
2,52E-02
proteasome complex (sensu 
Eukaryota) (GO:0000502)
4,21E-02
intracellular organelle 
(GO:0043229)
4,21E-02
Functional groups regulated in liver whole genome analysis. 
Functional enrichment analysis performed in FatiGO http://
www.babelomics.org/ by Fisher's exact test followed by FDR 
correction considering the number of functional groups tested.
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also likely to vary between tissues.
Even though the global transcriptional output from the X
chromosome is similar in males and in females [1], two
studies of genome-wide gene expression reported several
genes differentially expressed between the sexes in the
mouse [16,17]. Notably, Yang and collaborators [17] ana-
lyzed a large number of individuals (169 females and 165
males) and found several genes on the X chromosome more
highly expressed in females, in at least two tissues (of the
four included in the analysis). In this dataset Utx was
female-biased in all tissues analyzed (brain, liver, adipose
and muscle) and Eif2s3x, Ddx3x and 2610029G23Rik were
also female-biased in 3 of the four tissues. Only those genes
with a minimum of 3-fold differential expression between
sexes were reported by Rinn and colleagues [16] but, in a
reanalysis of their data, we found that Eif2s3x is signifi-
cantly overexpressed in female hypothalamus; Utx, Ddx3x
and 2610029G23Rik, amongst others, presented a fold
change of 1.2 or higher in at least one of the tissues (kidney,
liver and hypothalamus), although not reaching the thresh-
old of significance. The fact that a much larger number of
genes is female-biased in at least two tissues (56 genes at P
< 0.05) in the comparison performed by Yang et al. [17] is
most likely due to their larger sample size. Although some
of these differences may be caused by other factors not
directly related to the chromosome complement, such as
sex-specific hormonal influences, the fact that several of
the genes were consistently overexpressed in both male/
female comparisons and in our analysis of XX and XO
mice suggests that some may indeed escape X inactivation.
In agreement with these results, Ddx3x is indeed expressed
from the inactive X chromosome in the mouse (L. Carrel,
personal communication).
In our study, two new candidates tested were concordant
at P < 0.05 by both approaches, in at least one of the tissues
(2610029G23Rik and Pnck). Although higher expression of
Pja1 in the liver and kidney of XX females was also
observed by qPCR, the difference did not reach significance
by this method. Both Pnck and Pja1 are female-biased in
the adipose tissue according to the data of Yang et al.[17].
Additionally, several of the genes that were significant in
liver in our microarray analysis but were not confirmed by
qPCR (Ogt, Maob,Ndufa, Pgrmc1 and Nsbp1) are amongst
the genes that are female-biased in at least one tissue,
according to the data of Yang et al. [17]. In the latter study
most of the sex differences in gene expression were modest
(FC < 1.2) and the authors did not perform qPCR experi-
ments to confirm them.
Further evidence in support of the existence of uncharac-
terised escapees on the rodent X chromosome comes from
studies in mouse ES cell lines [15,44]. However, in the
absence of direct evidence of escape from X inactivation
from our allele-specific analysis, two alternative hypothesis
must be considered: i) the three genes tested (Huwe1,
Arhgef6 and Nsbp1) are false positives generated by the sta-
tistical analyses of differential expression by microarray
(both in our study and in the study of Yang et al.); ii) over-
expression of these genes in XX females may be due to a
secondary transcriptional upregulation of the active X chro-
mosome allele and does not reflect expression from both X
chromosomes, as discussed above. The former hypothesis
would imply a bias skewing the results in the same direc-
tion in two independent studies using different microarray
platforms and a different study design, which is unlikely.
On the other hand, the fact that these three genes present
binding sites for common transcription factors gives
strength to the second hypothesis, where overexpression of
some X-linked genes would be due to transcriptional upreg-
ulation, through the same mechanism that is contributing to
higher expression of several autosomal genes in XX
females.
Our results, as well as the results from other studies using
both in vitro and in vivo models suggest the existence of tis-
sue- or cell type-specific patterns of X inactivation. How-
ever this issue can only be fully addressed by a thorough
gene-by-gene comparison of allelic expression in single cell
versus whole tissue homogenates.
Relevance for understanding the molecular basis of Turner 
Syndrome
In humans, complete or partial monosomy of the X chro-
mosome results in Turner syndrome. The phenotype, which
includes ovarian dysgenesis and infertility, is attributed to a
lower dosage of X chromosome genes escaping inactiva-
tion. However, only 5% of the genes on the human X chro-
mosome that are expressed in lymphoblastoid cell lines are
significantly overexpressed in females at the population
level [37]. Therefore, only a small number of genes are pre-
dicted to contribute to dosage imbalances in X chromosome
aneuploidies.
We detected lower expression of several X-linked genes
in XO mice. Moreover, a large number of autosomal genes
were differently expressed between the two genotypes in
liver, including two genes which are mutated in POF -
Eif2b2 and Eif2b5 [36]. Due to the high number of genes on
the X chromosome involved in ovarian and oocyte develop-
ment it will be interesting in the future to analyse X-linked
expression in the ovary. However the tissue composition of
this organ is highly heterogeneous, including both somatic
and germinal cell lineages and therefore reactivation of the
inactive X chromosome during oogenesis is a confounding
factor that must be considered.
The analysis of functional enrichment we performed in
the liver dataset revealed other cellular processes that are
differently regulated between the two groups of mice ana-
lyzed - ATP synthesis and mitochondrial metabolism.
Impairment of energy metabolism is expected to lead to
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a prominent role in the pathogenesis of neurological dis-
eases. These results may therefore have a bearing on some
of the observed neuropsychological deficits of TS. The
presence of binding sites for shared transcription factors
within the regulatory regions of the genes underexpressed
in XO mice reinforced the hypothesis of a deregulation of
specific pathways in this model.
Although X-linked imprinted genes can also contribute to
some of the phenotypes observed in TS females, parental
effects on expression have so far only been detected in
some genes of the Xlr family [24,43]. In our analysis no rel-
evant differences were found between XmO and XpO mice.
Conclusion
We confirmed and extended previous global analysis of X
chromosome gene expression in the mouse and uncovered a
dosage-dependent effect on the expression levels of several
X-linked and autosomal genes that cannot be attributed to
sex-specific hormonal influences. Even though we found
strong candidates for escaping X inactivation, the lack of
direct evidence of escape for those genes tested suggests
that other factors may underlie the differences observed
between XX and XO mice.
Several X-linked and autosomal genes are deregulated in
XO mice and these are involved in a variety of cellular
functions. We hypothesize that the TS phenotype is par-
tially caused by the additive effect of regulatory perturba-
tions downstream of the under-expressed X-linked genes,
which may differ between tissues and between species.
Moreover, genes escaping inactivation in humans but not in
the mouse may lie in regulatory nodes at the intersection of
a larger number of effectors, having a greater impact on
genome-wide levels of expression.
Methods
Subjects
The mouse models used in our expression analysis were
obtained as described in [24], except that in our experiment
the X chromosomes of the random bred MF1 genetic back-
ground derived from a single progenitor X and thus are the
same for all individuals analyzed (XmO, XpO and XmXp).
All genotypes were determined by bone marrow metaphase
preparations and in some cases confirmed by PCR. All ani-
mal procedures and breeding were in accordance with the
United Kingdom Animal Scientific Procedures Act 1986
and were subject to local ethical review.
RNA extraction
Tissues from 12 week old mice were harvested and stored
at -80°C before use. Total RNA was isolated from homoge-
nized tissues using Trizol reagent (Invitrogen) and purified
using the RNeasy Kit (Qiagen) according to the manufac-
turer's instructions. RNA integrity was verified by capillary
electrophoresis in the Agilent 2100 Bioanalyzer.
Gene expression quantification in 40,XX and 39,XO mice
The RNA samples of seven 40,XX, eight 39,XpO and eight
39,XmO mice were pooled by genotype into 9 groups, rep-
resenting 3 biological replicates per genotype, as follows:
39,XpO-1 and 39,XpO-2 (3 pooled individuals each),
39,XpO-3 (2 pooled individuals); 39,XmO-1 and 39,XmO-2
(3 pooled individuals each), 39,XmO-3 (2 pooled individu-
als); 40,XX-1 and 40,XX-2 (3 pooled individuals each)
40,XX-3 (2 pooled individuals). A total of 300 ng of RNA
from each pool was then amplified following the Illumina
TotalPrep RNA amplification protocol. The samples were
labelled and hybridized to the Mouse WG-6 v1_1 Expres-
sion BeadChip whole genome expression array available
from Illumina, following the manufacturer's protocols.
Array data extraction, normalisation and analysis
The values for each bead in the array were imported into the
Illumina software BeadStudio for preliminary quality
checks, summarized according to bead type and then
exported into R environment for statistical computing. Nor-
malisation across all arrays was performed on a log scale
using the quantile normalisation method [45] implemented
in lumi normalisation package [46]. The normalised inten-
sity values were used for independent pairwise comparisons
for each tissue, using the empirical Bayes approach imple-
mented in limma by assigning the samples to two groups
according to genotype (40,XX and 39,XO). Only probes
detected as present in at least one the samples in each tissue
were compared. The p-values were then subjected to the
FDR correction[47].
Samples were hierarchically clustered using the tools
implemented in InforSense Workflow Builder http://
www.inforsense.com. The distance matrix was calculated
with Pearson correlation and clusters built by average link-
age.
The microarray data for this study have been deposited to
GEO under accession number GSE13520.
Quantitative Real-Time PCR
Quantitative real-time PCR reactions were carried out using
100 ng of cDNA in a reaction volume of 20 μl comprising
Sybr Green PCR Master Mix (Applied Biosystems) and 0.3
μM of each primer in an Applied Biosystems 7000 detec-
tion system (Applied Biosystems). Efficiency of primers
and quantity of cDNA in each well were derived from an
experimentally determined standard curve; only reactions
with r2 ≥ 0.99 and with a standard curve slope typically -3.1
≤ S ≤ -3.6 were accepted. Melt curve data were obtained to
confirm amplification of the correct product. Expression
was normalised by reference to Gapdh and in most cases
the results were confirmed using Actb. Differences in
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test. All primers were designed to span exon-exon boundar-
ies, to prevent amplification of possible genomic DNA con-
taminants. For primer sequences see Additional file 2.
Analysis of allelic expression
Expression from each X chromosome was verified using
polymorphisms within the coding region and/or the UTRs
of Huwe1, Arhgef6 and Nsbp1 by direct sequencing and,
whenever possible, by single-base primer-extension (SNaP-
shot). Each SNaPshot assay was tested in genomic DNA of
T16H-FVB F1 females heterozygous for the target SNPs
and then used to differentiate expression from each X chro-
mosome in the cDNAs from liver, kidney, muscle and brain
of two animals. Typically 50 ng of DNA and 100 ng of
cDNA were amplified using the HotStar HiFidelity Poly-
merase Kit (Qiagen) in a 10 μl reaction volume comprising
0.3 μM of each primer. PCR conditions were the following:
15 min pre-incubation step at 94°C, 35 cycles of denatur-
ation at 94°C for 30 sec, annealing for 45 sec at the respec-
tive AT for each primer pair and extension at 72°C for 45
sec, followed by a final extension step at 72°C for 10 min.
The PCR products were then purified with ExoSAP-IT
(Usb) and single-base primer-extension reactions were car-
ried out with SNaPshot Multiplex Kit (Applied Biosystems)
in a 5 μl volume comprising 0.2 μM of the extension primer
and up to 2 μl of the purified PCR product (depending on
the expression level of each gene in the different tissues
tested), for 25 cycles. SNaPshot reactions were cleaned up
with Shrimp Alkaline Phosphatase (Usb) and the analysis
of fluorescent products was performed in an ABI 3100
sequencer using the GeneMapper 4.0 Analysis Software.
For primer sequences see Additional file 2.
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